Rowan Gardner (@rowanbio.bsky.social) will present new DecodeME analysis at #IIMEC18: 'Expanding Mechanistic Insights in ME - Analysis of DecodeME population and what’s next' New insights into ME/CFS and long COVID biology, patient stratification, and future research directions. #MECFS #LongCOVID

Our new paper out today in Nature Comms, led by the amazing @profmarkfaghy.bsky.social Current status and future perspectives on the mechanistic And pathophysiological understanding of Long Covid www.nature.com/articles/s43...

PrecisionLife & Ovation are bringing precision medicine to GLP-1s - with new genetic markers predicting response and tests launching in 2026. This creates a significant opportunity to improve outcomes for patients, payors, providers, and pharma. Learn more here: precisionlife.com/news-and-eve...

Presenting new research at #EEC2026 Our talk on genomic signatures of female #infertility in #endometriosis & related conditions was selected for the best abstracts session. 24 Apr | 11:30 Krystyna Taylor presenting

There's still time to sign up for our second workshop for our PRIME research project! 📅 When? Friday 24 April, 2-5pm GMT 📍 Online 🔗 Register to attend: us02web.zoom.us/webinar/regi... 👉 Read the full programme: www.actionforme.org.uk/prime-worksh...

Very excited to see how fast these insighgts emerge with top quality data from @precisionlife.bsky.social partner Ovation. precisionlife.com/news-and-eve... #genomics #PMWC #precisionmedicine 🧬🖥️

Wear pink Tues Jan 13th at #JPM26 to recognize impact of women leaders & allies in bio. Wear a pink shirt, tie or socks if you don’t own a pink blazer. We had an incredible turnout at inaugural event at #JPM25 w/ pink visible throughout the streets of SF. Join group pic at 4pm #BiotechCEOSisterhood

Well Done @rhodri.biz Please donate and enjoy #duvetknowitschrismas

I hap the pleasure of a conversation with Callum at Divinity Schools Oxford recently. We discussed the challenges of growing SME life science businesses in the UK. www.libdems.org.uk/mps/bicester...

Those lovely people @actionforme.bsky.social have shared the recording of the webinar covering presentation of @precisionlife.bsky.social LOCOME results. #MECFS #longcovid www.youtube.com/watch?v=ITZ3...

(4/4) 👉 Register here: us02web.zoom.us/webinar/regi...

Delighted how @precisionlife.bsky.social and @actionforme.bsky.social et al used consented @decodemestudy.bsky.social data to -replicate #MEcfs genetic signal & -show its shared/distinct genetics with Long Covid. Next: replicate ME/CFS subtypes w/ targeted therapies www.medrxiv.org/content/10.6...

(1/4) 🧬 @precisionlife.bsky.social has released exciting results from the LOCOME project Using DecodeME and other datasets, LOCOME has identified a number of genetic signals and biological pathways that may be involved in ME.

New myalgic encephalomyelitis (ME, also known as ME/CFS) genetics study reveals 250+ core genes, shared mechanisms with long COVID, and dozens of drug repurposing opportunities. This would not have been possible without the thousands of people with ME who contributed their data. Thank you.

Latest news from @precisionlife.bsky.social and our partners Ovation (ovation.io). www.prnewswire.com/news-release... 🧬🖥️

London Life Sciences Week (LLSW) returns on 🗓️ 16-21 November 2025 ➡️ shorturl.at/YbDgZ #LLSW offers an exceptional platform to connect, collaborate, and explore the latest innovations in the sector. Stay tuned for updates and registration info via our website. We look forward to seeing you there! 🤝

Thank you to Golda Arthur for inviting me to be on the Overlooked Pod. A curation of conversations about women's health from patients, clinicians and scientists. Highlighting @precisionlife.bsky.social's work in #endometriosis and #womenshealth check out the series overlookedpod.com/episode/a-ne...

The BBC License fee is brilliant value for money. Presented by Ella Al-Shamahi, Human brings together cutting-edge DNA science, global archaeology, and breathtaking visuals to tell this ambitious story in a totally new way. #genomics www.bbc.co.uk/iplayer/epis... www.youtube.com/shorts/cFxF6...

🎥 As part of today’s recognition of #SevereME, we’re sharing this recent presentation by our Co-founder, Rowan Gardner (@rowanbio.bsky.social‬), given at International ME Conference: 𝗣𝗿𝗲𝗰𝗶𝘀𝗶𝗼𝗻 𝗗𝗶𝗮𝗴𝗻𝗼𝘀𝘁𝗶𝗰 𝗧𝗲𝘀𝘁𝘀 𝗮𝗻𝗱 𝗣𝗲𝗿𝘀𝗼𝗻𝗮𝗹𝗶𝘇𝗲𝗱 𝗧𝗿𝗲𝗮𝘁𝗺𝗲𝗻𝘁𝘀 𝗳𝗼𝗿 𝗠𝗘.

Honored to speak at the @investinmeresearch.bsky.social conference. My mother is disappointed that my hair is a mess. Sorry Mum!

Millions are still waiting for answers. Ahead of #SevereMEAwarenessDay, we’re reaffirming our support and using genetic insights to develop the first non-invasive mechanostic tests to accelerate diagnosis and improve care. 🔗 precisionlife.com/blog-support... #MECFS #LongCOVID

FAQs on the #DecodeME #MECFS results www.decodeme.org.uk/faqs/

Our initial DNA results! DecodeME have discovered that people with an ME/CFS diagnosis have significant genetic differences compared to the general population. - Summary of our results: shorturl.at/pgsjk Check out our full preprint paper: shorturl.at/VwN3s

We fully support our partners at @actionforme.bsky.social in their response to the UK government's ME/CFS Delivery Plan as a positive and necessary step forward – but that much more is needed to deliver real change, faster, for people with ME. #pwME #MECFS #MyalgicE #MyalgicEncephalomyelitis

Exciting to see interest in developing more tools to interrogate the proteome. Work using @ukbiobank.bsky.social proteomics data by @precisionlife.bsky.social is showing that for some of our biggest healthcare challenges there is more predictive signal in the proteome for disease risk than DNA. 👏

Delighted to feature in the @bia-uk.bsky.social report on functional genomics as an example of its transformative power in UK healthcare. Proud to work at the intersection of AI and genomics - understanding complex biology to predict & prevent chronic diseases. 🔗 bioindustry.org/resource-rep...

I enjoyed Simon's presentation and insights into www.neuroproteome.org plans to share neurodegenerative proteomics data for 40,000 individuals. Great work funded by Gates Ventures. All 👀 on @naturemedicine.bsky.social in two weeks!

PrecisionLife CEO, Steve Gardner, spoke yesterday on BBC Radio 4’s Today Show about the UK industrial strategy & why prioritizing life sciences is vital for economic growth. #LifeSciences #PrecisionMedicine

New in Bio-IT World: how PrecisionLife is enabling mechanism-based precision medicine for complex diseases like ME/CFS, long COVID, ALS & endometriosis. Read the article: www.bio-itworld.com/news/2025/06... #precisionmedicine #biomarkers #PrecisionLife

This week was a big one for us as our policy team was in #Westminster alongside 50 senior figures from the UK #LifeSciences community, urging bold #Government action to deliver much-needed growth for the #UKEconomy ➡️ shorturl.at/367is

Very sorry to miss @cgatist.bsky.social talk today at 14th International Biomedical Research into ME Colloquium 2025. It will be excellent! www.investinme.org/brmec14agend... 🖥️🧬 #MECFS #DECODEME

Rowan Gardner (@rowanbio.bsky.social) joins global leaders at Oxford Nanopore’s (@nanoporetech.com) Informatics Day tomorrow to discuss how AI and genomics can unlock new insights in complex disease biology. 🔗 nanoporetech.com/about/events... #LondonCalling25 #Genomics #AI #PrecisionMedicine

I am looking forward to Friday's informatics day. I am honoured to be asked to be on a panel. 🧬💻

investor.regeneron.com/news-release... I did not have Regeneron on my !who will buy 23andMe?" bingo card. However, with hindsight, it feels like an obvious outcome.

190 Million women are waiting. Endometriosis sufferers need more actionable clinical diagnoses and targeted treatment options.

We’re changing that. 🧬 We’ve identified novel genetic drivers of disease 🛡️ Discovered actively protective drug targets 🧪 Developed rapid, non-invasive diagnostic tools 💊 Initiated studies of repurposed, precision therapies 🎯 Enabled differential triage across overlapping syndromes

📢 This #WorldMEDay, we’re proud to share real progress towards better outcomes for people living with ME/CFS and Long COVID.

This is precision medicine in action — made possible through our #LOCOME project and partnerships across the UK and US. 👉 Explore our first-year progress in this visual summary — and read the full report on our website: precisionlife.com/mecfs

PrecisionLife & Metrodora confirm the first reproducible genetic signatures for #LongCOVID across ancestries. Just in time for #WorldMEDay, this marks major progress for patients with complex chronic conditions. 🔗 Read: precisionlife.com/publication-... #PrecisionMedicine #MECFS #Genomics

Very proud of our team @precisionlife.bsky.social and our partners today translational-medicine.biomedcentral.com/articles/10.... Reproducing insights across populations 🧬🖥️

How can biotech and pharma partner more effectively in CNS & neurology? 🧠 Catch @rowanbio.bsky.social and leaders from Otsuka, Eli Lilly, Avata Biosciences & Lumina Life Sciences at LSX World Congress to share strategies for success. #LSXWorld #CNS #Partnerships precisionlife.com/news-and-eve...

Out of the office next week. I am looking forward to discussions about how we develop more predictive and preventative healthcare provision and use precision medicine approaches to maximize health outcomes and reduce the cost of effective delivery of care #ADGHW precisionlife.com/news-and-eve...

On the basis of yesterday's book launch in Oxford, this will be a delightful opportunity to escape for a couple of hours into a another world. Lovely to see you @joannamillerauthor.bsky.social have now read The Eights, please write next one.

PrecisionLife Co-founder and Chief Business & Investment Officer, Rowan Gardner @rowanbio.bsky.social, will be chairing the sold out 𝗙𝗶𝗻|𝗧𝗲𝗰𝗵|𝗕𝗶𝗼 𝗮𝘁 𝗖𝗮𝗻𝗮𝗿𝘆 𝗪𝗵𝗮𝗿𝗳 event this evening. For more details about this and future events, visit: level39.co/event/fintec...

Thank you to @catelawrence.bsky.social for covering @precisionlife.bsky.social work in #LongCOVID. Great to be included in the @tech.eu platform. tech.eu/2025/03/17/i... #ILCAD2025

I am moderating the first Fin|Tech|Bio at Canary Wharf event of 2025. The series will convene innovators, investors and industry stakeholders at the intersection between finance, tech and biotech. Check out the panel, it's a doozy www.eventbrite.co.uk/e/fintechbio... #techbio #AIxBIO #LondonCalling

A UK-US study found 77-83% of long COVID disease signatures were reproducible, confirming genetic risk. Key genes: TLR4 (immune response), CCDC146 (cognition), D2HGDH (mitochondria), supporting drug repurposing efforts. www.medrxiv.org/content/10.1...

"Reproducibility of Genetic Risk Factors Identified for Long COVID using Combinatorial Analysis Across US and UK Patient Cohorts with Diverse Ancestries" www.medrxiv.org/content/10.1... Screenshot from latest Science for ME weekly update #LongCovid #PASC

Very pleased to see this study which demonstrates the value of the AllofUs population in enabling molecular etiology of disease to be evaluated in diverse genetic ancestries. Long Covid is estimated to have a Health + Socioeconomic Cost / Year of $1Trillion dollars.

Following the exciting announcement of our TRANSCEND project to advance precision medicine solutions for endometriosis (precisionlife.com/transcend-en...), we’re looking forward to attending the EndoFound Annual Medical Conference in NYC (Feb 28 – Mar 1). www.endofound.org/medicalconfe...